InvestorsHub Logo
Followers 71
Posts 7713
Boards Moderated 0
Alias Born 09/28/2012

Re: None

Wednesday, 07/29/2020 9:16:48 AM

Wednesday, July 29, 2020 9:16:48 AM

Post# of 232890
CD10, 12 endpoints. NP will need help not to fumble the data analysis. One could argue he needed help to set the endpoints for the protocol. I’ve heard the CD10/12 end points weren’t set up for LL to win.

Inexperience could seriously weigh down the effectiveness of LL.

I think the FDA knows LL is the real deal... they are just dealing with a rookie pharma co.

These guys need help.... LL reminds me of a great #1 draft pick QB and no offensive line.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News